AU6708598A - Method and reagent for inhibiting cancer development - Google Patents

Method and reagent for inhibiting cancer development

Info

Publication number
AU6708598A
AU6708598A AU67085/98A AU6708598A AU6708598A AU 6708598 A AU6708598 A AU 6708598A AU 67085/98 A AU67085/98 A AU 67085/98A AU 6708598 A AU6708598 A AU 6708598A AU 6708598 A AU6708598 A AU 6708598A
Authority
AU
Australia
Prior art keywords
reagent
cancer development
inhibiting cancer
inhibiting
development
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU67085/98A
Other versions
AU730506B2 (en
Inventor
Kenneth G. Draper
James D. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Ribozyme Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/936,421 external-priority patent/US5750390A/en
Priority claimed from US07/936,110 external-priority patent/US5610052A/en
Priority claimed from US07/936,532 external-priority patent/US6492512B1/en
Priority claimed from AU42489/93A external-priority patent/AU687001B2/en
Application filed by Ribozyme Pharmaceuticals Inc filed Critical Ribozyme Pharmaceuticals Inc
Publication of AU6708598A publication Critical patent/AU6708598A/en
Application granted granted Critical
Publication of AU730506B2 publication Critical patent/AU730506B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU67085/98A 1992-05-14 1998-05-19 Method and reagent for inhibiting cancer development Ceased AU730506B2 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US88288592A 1992-05-14 1992-05-14
US88282292A 1992-05-14 1992-05-14
US882885 1992-05-14
US882822 1992-05-14
US93653192A 1992-08-26 1992-08-26
US93642292A 1992-08-26 1992-08-26
US07/936,421 US5750390A (en) 1992-08-26 1992-08-26 Method and reagent for treatment of diseases caused by expression of the bcl-2 gene
US936110 1992-08-26
US936421 1992-08-26
US936422 1992-08-26
US07/936,110 US5610052A (en) 1992-08-26 1992-08-26 Enzymatic RNA with activity to ras
US936532 1992-08-26
US936531 1992-08-26
US07/936,532 US6492512B1 (en) 1992-08-26 1992-08-26 Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression
US98713192A 1992-12-07 1992-12-07
US987131 1992-12-07
US612293A 1993-01-19 1993-01-19
US891093A 1993-01-19 1993-01-19
US006122 1993-01-19
US008910 1993-01-19
AU42489/93A AU687001B2 (en) 1992-05-14 1993-05-13 Method and reagent for inhibiting cancer development

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU42489/93A Division AU687001B2 (en) 1992-05-14 1993-05-13 Method and reagent for inhibiting cancer development

Publications (2)

Publication Number Publication Date
AU6708598A true AU6708598A (en) 1998-08-27
AU730506B2 AU730506B2 (en) 2001-03-08

Family

ID=27581358

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67085/98A Ceased AU730506B2 (en) 1992-05-14 1998-05-19 Method and reagent for inhibiting cancer development

Country Status (1)

Country Link
AU (1) AU730506B2 (en)

Also Published As

Publication number Publication date
AU730506B2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
EP0641212A4 (en) Method and reagent for inhibiting cancer development.
AU6400596A (en) Access portal and method
AU4609093A (en) Method and kit for detecting explosives
AU1075695A (en) Method for diagnosing cancer
AU4230193A (en) Method and system for topograhic measurement
AU6239894A (en) A method and system for sampling and determining the presence of compounds
AU675671B2 (en) System and method for knowledge based design
IL117177A0 (en) Benzopyran-containing compounds and method for their use
AU5268696A (en) Novel compounds and methods for therapy
AU6811696A (en) Radiation based method for locating and differentiating sentinel nodes
AU3475493A (en) Method and apparatus for locating tumors
EP0851759A4 (en) Compounds and methods
AU6400294A (en) Tripterinin compound and method
AU2582195A (en) Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU5407994A (en) Method for particulate reagent sample treatment
AU5543494A (en) Method and kit for cancer diagnosis
AU4489693A (en) Apparatus and methods for improved construction
AU5339394A (en) Method and apparatus for bioaffinity assays
GB2284054B (en) Method for range determination
AU3697393A (en) Method for the elimination of non-specific reactions in immunoassays
GB2266167B (en) Communicating system and method for communicating data
HUP9904330A3 (en) Perfluoroalkylation method and reagent therefor
AU6012696A (en) Prognostic and therapeutic system for cancer
AU3973793A (en) Method of treating cancer
AU3177893A (en) Method for diagnosing and treating cancer

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)